Aypa Power, a Blackstone portfolio company and leading developer, owner, and operator of utility-scale energy storage and hybrid renewable energy projects, has announced the closing of its US$1.5 billion construction
Aypa Power, a Blackstone portfolio company and leading developer, owner, and operator of utility-scale energy storage and hybrid renewable energy projects, has announced the closing of its US$1.5 billion construction
Skyryse, a leader in aviation automation and simplified flight controls, has announced that it successfully raised over US$300 million in a new Series C investment to drive continued growth and
DLA Piper advised the underwriting syndicate led by Oppenheimer & Co. and Canaccord Genuity in Public Policy Holding Company, Inc.’s (PPHC)’s US$50.8 million US initial public offering (IPO) and listing
Satellos Bioscience Inc. (TSX: MSCL, Nasdaq: MSLE) (the company), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, has announced the pricing of its previously announced public
Latham & Watkins represented the financing source in AssetMark’s upsized and repriced US$2.165 billion senior secured credit facilities. Partner Jesse Sheff led the Latham team, along with partner Brianna Oller,
Linklaters has advised a group of lenders composed of the International Finance Corporation (IFC), Deutsche Investitions- und Entwicklungsgesellschaft mbH (DEG) and The Emerging Africa & Asia Infrastructure Fund (EAAIF) on
The Crans-Montana, Switzerland – February 2026. The consequences of one of the deadliest nightclub tragedies in Swiss history have become a matter of global controversy concerning the issue of forensic
SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma), a late-stage biopharmaceutical company, has announced the pricing of its initial public offering of 9,375,000 shares of its common stock at a public
Being injured in a motor vehicle accident, unfortunately, can turn the victim’s life upside down instantly. Medical bills pile up, work becomes difficult or impossible, and insurance companies often move
Latham & Watkins has advised CVC, one of the world’s leading private markets investment firms, on the sale of a minority stake in Rayner, a global leader in ophthalmic innovation,